We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$323B
AUM Growth
+$11.5B
Cap. Flow
+$13.1B
Cap. Flow %
4.05%
Top 10 Hldgs %
14.39%
Holding
7,731
New
673
Increased
3,224
Reduced
3,031
Closed
497

Sector Composition

Rank Sector Weight
1 Financials 8.41%
2 Healthcare 8.04%
3 Technology 7.66%
4 Energy 6.94%
5 Consumer Discretionary 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWOU
4776
CALL
DELISTED
2U Inc
TWOU
$724K ﹤0.01%
+750
New +$623K
CEO
4777
CALL
DELISTED
CNOOC Limited
CEO
$724K ﹤0.01%
5,100
+2,300
+82% +$363K
AMKR icon
4778
PUT
Amkor Technology
AMKR
$12.4B
$723K ﹤0.01%
120,900
+55,200
+84% +$398K
YCS icon
4779
ProShares UltraShort Yen
YCS
$29.9M
$723K ﹤0.01%
+31,356
New +$713K
CLNE icon
4780
PUT
Clean Energy Fuels
CLNE
$427M
$722K ﹤0.01%
128,500
+55,200
+75% +$414K
MDGL icon
4781
Madrigal Pharmaceuticals
MDGL
$10.8B
$722K ﹤0.01%
9,250
-1,861
-17% -$156K
DMND
4782
CALL
DELISTED
DIAMOND FOODS, INC.
DMND
$722K ﹤0.01%
23,000
+1,600
+7% +$48.6K
COLL icon
4783
Collegium Pharmaceutical
COLL
$1.15B
$721K ﹤0.01%
+40,430
New +$699K
CPB icon
4784
CALL
Campbell Soup
CPB
$6.55B
$720K ﹤0.01%
15,100
CSTE icon
4785
CALL
Caesarstone
CSTE
$72.3M
$720K ﹤0.01%
10,500
+1,300
+14% +$80.3K
DGX icon
4786
CALL
Quest Diagnostics
DGX
$25.7B
$718K ﹤0.01%
9,900
-11,400
-54% -$842K
FLEX icon
4787
PUT
Flex
FLEX
$41.7B
$714K ﹤0.01%
83,734
-5,971
-7% -$55K
TGTX icon
4788
TG Therapeutics
TGTX
$7.96B
$714K ﹤0.01%
43,053
+17,501
+68% +$277K
NXTM
4789
PUT
DELISTED
NxStage Medical Inc.
NXTM
$714K ﹤0.01%
+50,000
New +$847K
SRS icon
4790
PUT
ProShares UltraShort Real Estate
SRS
$15.3M
$713K ﹤0.01%
1,631
+672
+70% +$267K
SGI
4791
CALL
Somnigroup International
SGI
$13.7B
$712K ﹤0.01%
43,200
+22,400
+108% +$342K
WUBA
4792
CALL
DELISTED
58.com Inc
WUBA
$711K ﹤0.01%
11,100
+2,900
+35% +$211K
GAME
4793
DELISTED
SHANDA GAMES LTD SPON ADR REPSTG CL A (CAYMAN ISLANDS)
GAME
$708K ﹤0.01%
102,825
-49,904
-33% -$343K
CSTE icon
4794
PUT
Caesarstone
CSTE
$72.3M
$706K ﹤0.01%
10,300
-6,900
-40% -$426K
STMP
4795
DELISTED
Stamps.com, Inc.
STMP
$706K ﹤0.01%
9,597
-2,302
-19% -$158K
ASX icon
4796
ASE Group
ASX
$77.3B
$705K ﹤0.01%
106,858
+8,672
+9% +$60.4K
OMER icon
4797
Omeros
OMER
$857M
$704K ﹤0.01%
39,120
+26,528
+211% +$572K
GDXS
4798
DELISTED
ProShares UltraShort Gold Miners
GDXS
$704K ﹤0.01%
7,000
-28,375
-80% -$2.45M
DANG
4799
PUT
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
$703K ﹤0.01%
78,200
+30,200
+63% +$284K
ANK
4800
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
$700K ﹤0.01%
10,127
-1,592
-14% -$110K

Similar funds

Goldman Sachs's Q2 2015 Portfolio in Review

As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.

By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.

  • Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
  • Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
  • Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
  • Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
  • Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
  • Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.